Morad K. Nakhleh Joined Owlstone in 2018 and performs as Head Commercial Biomarker Strategist. In his role, Morad supports the development of scientific and technical solutions, based on exhaled VOCs analysis, for clinical applications. Morad has over 11 years of experience in biomarker discovery and exhaled breath analysis. He holds a first degree in Emergency medicine, master’s degree in medical sciences and PhD in Nano-biotechnology. Prior to joining Owlstone, as part of his post-doctoral research, Morad focused on investigating the origins and biochemistry of VOCs, mainly in respiratory diseases.